Emerging Therapies Plaque Psoriasis

Calcipotriene betamethasone foam phase 3 trial succeeds
July 27, 2020

Twice-weekly treatment with calcipotriene-betamethasone diproprionate provides safe and effective maintenance treatment for plaque psoriasis, according to phase 3 data.

Therapeutic, management considerations with biologics
July 24, 2020

Studies offer further insight into risks associated with biologic therapy. One study suggests it’s not necessary to stop biologic therapy preoperatively to limit post-operative infections. Another systematic review does not rule out melanoma risk.

Bimekizumab phase 3 data reflect rapid, durable response
June 29, 2020

Phase 3 data announced at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2020 demonstrate that the second-generation IL-17 inhibitor may offer long-lasting, safe treatment for patients with psoriasis.